- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Growth Potential Companies
Indian Pharmaceuticals & Biotech High Growth Potential Companies
Results
40
Companies with a Future performance score of at least 3, ordered by Future performance score.
40 companies
Divi's Laboratories
Market Cap: ₹1.6t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹5,689.50
7D
-8.2%
1Y
4.2%
Blue Jet Healthcare
Market Cap: ₹115.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹645.90
7D
-4.9%
1Y
25.4%
Marksans Pharma
Market Cap: ₹76.8b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹164.38
7D
-8.2%
1Y
-46.2%
Caplin Point Laboratories
Market Cap: ₹165.7b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,037.40
7D
-13.1%
1Y
6.6%